Identical results of primary percutaneous transluminal coronary angioplasty in patients with acute myocardial infarction referred directly and indirectly;Gelijke resultaten van primaire percutane transluminale coronaire angioplastiek bij direct en indirect verwezen patienten met acuut myocardinfarct

Nederlands Tijdschrift voor Geneeskunde

Volumn 143, Issue 10, 1999, Pages 521-524

  Zijlstra, F ^a   Suryapranata, H ^a   Van't Hof, A W J ^a   Hoorntje, J C A ^a   Liem, A L ^a   De Boer, M J ^a  

^a HOSPITAL DE WEEZENLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRINOLYTIC AGENT;

ACUTE HEART INFARCTION; ADULT; ARTICLE; CARDIOGENIC SHOCK; CORONARY ARTERY BYPASS GRAFT; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PATIENT REFERRAL; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PATIENT TRANSFER; PROSPECTIVE STUDIES; RECURRENCE; REFERRAL AND CONSULTATION; SURVIVAL RATE;

EID: 0033528534     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Second International Study of Infarct Survival (ISIS)-2 Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17.187 cases of suspected acute myocardial infarction. Lancet 1988;ii:349-60.
2. Yusuf S, Peto R, Lewis J, Collins R, Sleight P. Beta blockade during and after myocardial infarction: an overview of the randomized trials. Prog Cardiovasc Dis 1985;27:335-71.
3. Simoons ML. Myocardial infarction: ACE inhibitors for all? For ever? Lancet 1994;344:270-81.
4. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;i:397-402.
5. The GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993;329:673-82.
6. Weaver WO, Simes RJ, Betriu A, Grines CL, Zijlstra F, Garcia E, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997;278:2093-8.
7. Liem AL, Zijlstra F. Gunstige lange-termijnresultaten van primaire percutane transluminale coronaire angioplastiek wegens acuut myocardinfarct vergeleken met intraveneuze streptokinasebehandeling; cen gerandomiseerd onderzoek. Ned Tijdschr Geneeskd 1995;139: 2564-7.
8. Zijlstra F, Hof AWJ van 't, Liem AL, Hoorntje JCA, Suryapranata H, Boer MJ de. Transferring patients for primary angioplasty: a retrospective analysis of 104 selected high risk patients with acute myocardial infarction. Heart 1997;78:333-6.
9. Smith D, Dean J. Transferring patients for primary angioplasty. Heart 1997;78:323-4.
10. Lim R, Walters MI, Norell MS. Transferring patients for primary infarct angioplasty. Heart 1997;78:323-6.
11. Brodie BR. When should patients with acute myocardial infarction be transferred for primary angioplasty? Heart 1997;78:327-8.
12. Smyth DW, Elliott JM. Treating coronaries, at home or away? Heart 1997;78:329-30.
13. Boer MJ de, Hoorntje JCA, Ottervanger JP, Reiffers S, Suryapranata H, Zijlstra F. Immediate coronary angioplasty versus intravenous streptokinase in acute myocardial infarction: left ventricular ejection fraction, hospital mortality and reinfarction. J Am Coll Cardiol 1994;23:1004-8.
14. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Acute myocardial infarction: pre-hospital and in-hospital management. Eur Heart J 1996;17:43-63.
15. Zijlstra F, Beukema WP, Hof AWJ van 't, Liem AL, Reiffers S, Hoorntje JCA, et al. Randomized comparison of primary coronary angioplasty with thrombolytic therapy in low risk patients with acute myocardial infarction. J Am Coll Cardiol 1997;29:908-12.
16. Elsman P, Alleman MA, Zijlstra F, Ziektebeelden die het acute hartinfarct imiteren; valkuilen voor de behandeling. Ned Tijdschr Geneeskd 1998;142:1057-60.
17. Zijlstra F, Boer MJ de. Chirurgische interventies bij het acute myocardinfarct. Ned Tijdschr Geneeskd 1996;140:1933-5.
18. Kimmel SE, Berlin JA, Laskey WK. The relationship between coronary angioplasty procedure volume and major complications. JAMA 1995;274:1137-42.
19. Christian TF, O'Keefe JH, DeWood MA, Spain MG, Grines CL, Berger PB, et al. Intercepter variability in outcome for patients treated with direct coronary angioplasty during acute myocardial infarction. Am Heart J 1998;135(2 Pt 1):310-7.
20. Bakhuizen R, Zijlstra F. Samenvatting plan van aanpak uitbreiding hartcentra d.d. 24 juni 1997. Cardiologic 1997;4:420.
21. O'Neill WW, Boer MJ de, Gibbons RJ, Holmes DR, Timmis GC, Sachs D, et al. Lessons from the pooled outcome of the PAMI, ZWOLLE and Mayo Clinic randomized trials of primary angioplasty versus thrombolytic therapy of acute myocardial infarction. Journal of Invasive Cardiology 1998;10:4A-10A.
22. Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996;348:771-5.
23. Hof AWJ van 't, Liem AL, Suryapranata H, Hoorntje JCA, Boer MJ de, Zijlstra F. Clinical presentation and outcome of patients with early, intermediate and late reperfusion therapy by primary coronary angioplasty for acute myocardial infarction. Eur Heart J 1998;19:118-23.
24. Boer MJ de, Hout BA van, Liem AL, Suryapranata H, Hoorntje JCA, Zijlstra F. A cost-effective analysis of primary coronary angioplasty versus thrombolysis for acute myocardial infarction. Am J Cardiol 1995;76:830-3.
25. Zijlstra F, Boer MJ de, Beukema WP, Liem AL, Reiffers S, Huysmans D, et al. Mortality, reinfarction, left ventricular ejection fraction and costs following reperfusion therapies for acute myocardial infarction. Eur Heart J 1996;17:382-7.
26. Lieu TA, Lundstrom RJ, Ray GT, Fireman BH, Gurley RJ, Parmley WW. Initial cost of primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 1996;28:882-9.
27. Hof AWJ van 't, Suryapranata H, Boer MJ de, Hoorntje JCA, Zijlstra F. Costs of stenting for acute myocardial infarction [letter]. Lancet 1998;351:1817.
28. Hochman JS, Boland J, Sleeper LA, Porway M, Brinker J, Col J, et al. Current spectrum of cardiogenic shock and effect of early revascularization on mortality. SHOCK Registry Investigators. Circulation 1995;91:873-81.